Recombinant human leptin treatment in genetic lipodystrophic syndromes: the long-term Spanish experience
Recombinant human leptin treatment in genetic lipodystrophic syndromes: the long-term Spanish experience is a paper indexed in ScholarIQ from OpenAlex.
How many citations does Recombinant human leptin treatment in genetic lipodystrophic syndromes: the long-term Spanish experience have?
Recombinant human leptin treatment in genetic lipodystrophic syndromes: the long-term Spanish experience has 50 citations in the OpenAlex counts ScholarIQ stores.
When was Recombinant human leptin treatment in genetic lipodystrophic syndromes: the long-term Spanish experience published?
Recombinant human leptin treatment in genetic lipodystrophic syndromes: the long-term Spanish experience has 2014 year in the ScholarIQ index.
What is the open-access status of Recombinant human leptin treatment in genetic lipodystrophic syndromes: the long-term Spanish experience?
Recombinant human leptin treatment in genetic lipodystrophic syndromes: the long-term Spanish experience has hybrid oa status in the ScholarIQ index.
What is the DOI of Recombinant human leptin treatment in genetic lipodystrophic syndromes: the long-term Spanish experience?
The DOI for Recombinant human leptin treatment in genetic lipodystrophic syndromes: the long-term Spanish experience is on the source record.
What is the PMID of Recombinant human leptin treatment in genetic lipodystrophic syndromes: the long-term Spanish experience?
The PMID for Recombinant human leptin treatment in genetic lipodystrophic syndromes: the long-term Spanish experience is on the source record.
What is the OpenAlex record for Recombinant human leptin treatment in genetic lipodystrophic syndromes: the long-term Spanish experience?
The OpenAlex for Recombinant human leptin treatment in genetic lipodystrophic syndromes: the long-term Spanish experience is on the source record.